The U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration issued joint warning letters to operators of two websites illegally selling Schedule II stimulants, including amphetamine drug products marketed as Adderall. These websites sell Adderall online without a prescription, which places consumers at risk.
ReutersWalgreens Boots Alliance Inc. supplied billions of opioid pills to drug addicts and criminals, contributing to an addiction epidemic in Florida, a lawyer for the state said on April 11 as a civil trial against the pharmacy chain got underway.
Florida reached more than $878 million in settlements with CVS Health Corp. and three drug companies to resolve claims and avert a trial in April over their roles in fueling an opioid epidemic in the third most populous U.S. state.
More than 14.5 million Americans signed up for Obamacare health insurance for 2022, a 21 percent jump over 2021 and the highest since the Affordable Care Act was signed 12 years ago, the U.S. government said on March 23.
BrandShield, together with the Pharmaceutical Security Institute, announced its findings following a disruption program carried out from December 2020 to November 2021 involving the monitoring, detecting and removal of online threats.
Ukraine is facing problems distributing medicines to pharmacies and hospitals due to the Russian invasion and wants to establish a humanitarian corridor for them, Health Minister Oleh Lyashko said on March 2.
CVS Health Corp. expects to administer 70% to 80% fewer COVID-19 vaccines in 2022 compared with 2021, adding that in-store diagnostic testing could fall 40% to 50%.
Merck & Co. and Ridgeback Biotherapeutics announced they have supplied about 3.1 million courses of their antiviral drug against COVID-19, molnupiravir, to the U.S. government. In other news, a study funded by the National Institutes of Health found that vaccination against COVID-19 not only protects pregnant women against the disease but their babies as well.
Medable Inc., the leading software provider for patient-centered clinical trials, launched the Medable Partner Network – uniting a diverse ecosystem of technology, service, data, site, and direct-to-patient partners that work together to accelerate deployment of decentralized clinical trials.
To address a lack of diversity, California-based Medable and CVS have forged a collaboration to improve patient access to clinical trial research.
